SCHEMBL7013502

SCHEMBL7013502

CCCCCC1CCC(Cc2c(CC)c(C(=O)C(N)=O)c3c(OCc4ccccc4)cccn23)CC1

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PLA2G1B P04054 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7015756 0.91 PLA2G1B (0.84) PLA2G1B
SCHEMBL7013003 0.90 PLA2G1B (0.81) PLA2G1B
SCHEMBL7017188 0.89 PLA2G1B (0.81) PLA2G1B
SCHEMBL7008318 0.89 PLA2G1B (0.81) PLA2G1B
SCHEMBL7017189 0.81 PLA2G1B (0.84) PLA2G1B
SCHEMBL7009883 0.80 PLA2G1B (0.85) PLA2G1B
SCHEMBL7011735 0.80 PLA2G1B (0.81) PLA2G1B
SCHEMBL7010025 0.80 PLA2G1B (1.00) PLA2G1B
SCHEMBL7014256 0.79 PLA2G1B (0.81) PLA2G1B
SCHEMBL7011894 0.79 PLA2G1B (1.00) PLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645976-B1 Nonpancreatic secretory phospholipase (sPLA2) supressors such as 2-(3-Benzyl-8-hydroxy-2-ethylindolizin-1-yl)acetamide, administered to control release of fatty acid and prevent the arachidonic acid cascade; septic shock ELI LILLY AND COMPANY 2003-11-11 US disclosed
EP-0772596-B1 INDOLIZINE sPLA2 INHIBITORS LILLY CO ELI (US) 2003-10-01 EP disclosed
EP-0772596-A4 INDOLIZINE sPLA2 INHIBITORS LILLY CO ELI (US) 1999-01-13 EP disclosed
EP-0772596-A1 INDOLIZINE sPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 1997-05-14 EP disclosed
WO-1996003383-A1 INDOLIZINE sPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 1996-02-08 WO disclosed